Evidence review
Generic Liraglutide: The Cheapest GLP-1 Almost Nobody Prices
Nine liraglutide generics are approved. One 30-day carton costs a pharmacy $288.20 — against $1,306.72 for a month of Wegovy pens. The catches are real.
"There is no generic GLP-1" is one of the most repeated sentences in this category, and it is not true. There has been one for a while, it comes in two different versions, and on the only neutral cost data anyone publishes it is far cheaper than everything else in the class.
It also has four catches, and they are not small. Both halves of that belong on the same page.
Nine approvals, two different drugs
Drugs@FDA lists nine liraglutide applications alongside the two Novo Nordisk originals.1 They split into two groups, and the split matters more than the count:
Referencing Victoza® (NDA 022341) — therapeutic-equivalence code AP1. Biocon ANDA 215245, Lupin ANDA 215421, Hikma ANDA 215503, Orbicular ANDA 217590, Nanjing King Friend ANDA 218115. These carry the type 2 diabetes label: an adjunct to diet and exercise to improve glycaemic control, dosed once daily at 0.6, 1.2 or 1.8 mg.2
Referencing Saxenda® (NDA 206321) — code AP2. Teva ANDA 214568, Biocon ANDA 217063, Orbicular ANDA 217234. These carry the weight-management label: to reduce excess body weight and maintain weight reduction long term, with a recommended dose of 3 mg daily reached by weekly increments from 0.6 mg.3
Both are 6 mg/mL solution in a 3 mL prefilled pen — 18 mg per pen. They are the same molecule with different labels and different pack sizes, and a quote for one is not a quote for the other.
What a pharmacy pays for a 30-day carton
CMS's NADAC survey reports what retail pharmacies pay wholesalers. On the file dated 5 August 2026, rates effective 22 July4:
Generic liraglutide, 3-pen carton (Hikma, NDC 0143-9144-03) — $32.02202 per mL × 9 mL = $288.20. At the diabetes label's 1.8 mg daily dosage, an 18 mg pen runs 10 days, so three pens is 30 days.
Victoza 3-pen carton — $87.83248 × 9 = $790.49. Identical pack, identical days.
Generic liraglutide, 5-pen carton (Teva, NDC 0480-7250-46) — $55.17226 × 15 mL = $827.58. At the weight label's 3 mg daily dosage an 18 mg pen runs 6 days, so five pens is 30 days.
Saxenda 5-pen carton — $87.16875 × 15 = $1,307.53. Identical pack, identical days.
The diabetes generic costs a pharmacy 36% of what the brand does — $502.29 less per carton. The weight generic costs 63% — $479.95 less.
And it is still falling
Generic prices decay as more applications reach the market, and this one is decaying fast. The same Hikma 3-pen carton on the file effective 17 December 2025 was $49.76053 per mL. On 22 July 2026 it was $32.02202. That is a 35.6% fall in seven months.4
The Teva 5-pen carton fell from $71.75767 per mL to $55.17226 over the same period — down 23.1%.
Nothing else in this class is moving in that direction. Every branded GLP-1 acquisition cost we checked was flat or slightly up across the same window.
Against the rest of the class
Acquisition cost per month of supply, same file, same effective date:
Generic liraglutide, diabetes carton — $288.20 (30 days)
Zepbound® KwikPen, 15 mg per dose — $670.23 (28 days)
Victoza 3-pen carton — $790.49 (30 days)
Generic liraglutide, weight carton — $827.58 (30 days)
Ozempic® pen — $995.81 (28 days)
Zepbound single-dose pen — $1,052.30 (28 days)
Mounjaro® pen — $1,077.21 (28 days)
Wegovy® 25 mg tablet — $1,301.50 (30 days)
Wegovy pen — $1,306.72 (28 days)
Saxenda 5-pen carton — $1,307.53 (30 days)
The cheapest thing in the class costs 22% of the dearest.
Four reasons this is not a simple win
You cannot buy it at that price, and we cannot tell you what you can buy it at. NADAC is a survey of pharmacy acquisition cost, not a retail price. No generic maker runs a direct-to-patient storefront like NovoCare Pharmacy or LillyDirect, so as of August 2026 there is no first-party published cash price for generic liraglutide anywhere. What a pharmacy charges you over that $288.20 is between you and the pharmacy.
It is a daily injection. Both labels dose liraglutide subcutaneously once daily.2 That is 365 injections a year against 52 for the weekly products. Whether that trade is worth several hundred dollars a month is a question about your life, not your budget.
One presentation is being retired. FDA's drug shortages data, queried on 7 August 2026, flags Teva's 5-pen carton — NDC 0480-7250-46, the weight-management generic priced above — as "To Be Discontinued", posted 14 May 2026.5 The other two weight-management applications, from Biocon and Orbicular, are not flagged. So the category is not disappearing; one company's version of it is.
The two versions are not interchangeable on the label. The AP1 generics carry a diabetes indication and a dosing ladder that tops out at 1.8 mg daily. The AP2 generics carry a weight-management indication and a recommended 3 mg daily. Which one a prescription is written against determines both what it treats and, at these pack sizes, what it costs.
Why nobody talks about it
Because there is no marketing budget behind a generic and no direct-to-patient storefront to publish a price. Novo built NovoCare Pharmacy and Lilly built LillyDirect; Hikma and Biocon built neither. The cheapest molecule in the class is the one with nobody advertising it, which is more or less the definition of a generic.
That does not make it right for anyone in particular — it is an older drug with a different dosing burden and a different evidence base, and none of that is a pricing question. It does mean that if cost is the constraint, it is worth asking a prescriber about by name.
What we could not price
We could not price generic liraglutide to a patient at all, for the reason above.
We could not compare it on effect. Doseworth prices things; it does not adjudicate clinical outcomes, and no figure on this page speaks to how any of these drugs perform.
And we could not find NADAC rows for the Biocon or Orbicular weight-management cartons in the 5 August file, so the only weight-management generic priced here is the one being discontinued.
Related: GLP-1 costs by dose, what NovoCare Pharmacy costs, and compounded semaglutide vs branded Wegovy — where the FDA's own distinction between a generic and a compounded drug does a lot of work.
Victoza®, Saxenda®, Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company.
Frequently asked questions
Is there a generic GLP-1?
Yes. Drugs@FDA lists nine approved liraglutide applications as of August 2026. Five reference Victoza and carry the type 2 diabetes label; three reference Saxenda and carry the weight-management label. There is no approved generic semaglutide or tirzepatide.
How much cheaper is generic liraglutide?
On CMS's NADAC acquisition data effective 22 July 2026, a three-pen generic carton costs a pharmacy $288.20 against $790.49 for the same Victoza carton — 36% of the brand. The five-pen weight-management generic carton is $827.58 against $1,307.53 for Saxenda, or 63%. For scale, a month of Wegovy pens costs a pharmacy $1,306.72.
Can I buy generic liraglutide at $288 a month?
No, and nobody can tell you what you can buy it at from a published source. NADAC measures what pharmacies pay wholesalers, not what patients pay at the counter. No generic manufacturer operates a direct-to-patient storefront comparable to NovoCare Pharmacy or LillyDirect, so as of August 2026 there is no first-party cash price for generic liraglutide to quote.
What are the drawbacks?
It is a once-daily injection rather than a weekly one, which is 365 injections a year instead of 52. The two versions carry different labels and different pack sizes and are not interchangeable. And FDA's shortage data flags one presentation — Teva's five-pen weight-management carton, NDC 0480-7250-46 — as 'To Be Discontinued' as of 14 May 2026, though the Biocon and Orbicular equivalents are not flagged.
References
- US Food and Drug Administration (2026). Drugs@FDA application records for liraglutide, including therapeutic-equivalence codes (queried 7 August 2026). openFDA drugsfda endpoint. https://api.fda.gov/drug/drugsfda.json?search=openfda.generic_name:%22liraglutide%22&limit=50
- Lupin Pharmaceuticals, Inc. (2026). Liraglutide injection — prescribing information (type 2 diabetes labelling). DailyMed, US National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0450d8a2-a88e-4849-9788-ed4f5246f223
- Teva Pharmaceuticals, Inc. (2026). Liraglutide injection — prescribing information (weight management labelling). DailyMed, US National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=625ac780-70a9-41e4-a892-bcba0f803f1c
- Centers for Medicare & Medicaid Services (2026). National Average Drug Acquisition Cost (NADAC), weekly file dated 5 August 2026; includes effective dates from 17 December 2025 to 22 July 2026. Medicaid.gov. https://download.medicaid.gov/data/nadac-national-average-drug-acquisition-cost-08-05-2026.csv
- US Food and Drug Administration (2026). Drug shortages database — liraglutide injection records including NDC 0480-7250-46, status 'To Be Discontinued', posted 14 May 2026 (queried 7 August 2026). openFDA drug shortages endpoint. https://api.fda.gov/drug/shortages.json?search=generic_name:%22Liraglutide%22&limit=30
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
What You Are Actually Buying When a Compounded GLP-1 Costs $99
A compounded GLP-1 price is set by federal compounding rules before it is set by anything else. What the FDA allows in 2026, and what it does to the number.
Read“Covered” Is Not a Price: What Your Plan Has Actually Promised
Covered means a drug is on a list. It does not mean a price, a fill, or a device. The four gates between a formulary entry and a dispensed prescription.
ReadCopay Cards: The Cap Is the Product
“Pay as little as $25” is a floor, not a price. What the manufacturer caps, who is excluded by name, and why card spending never touches your deductible.
ReadA $169 Month That Costs $2,028 on Day One
The “/mo” in a GLP-1 headline is often a division, not a charge. Four live prepay structures, the arithmetic behind each, and which discount badges survive it.
ReadThirteen Charges, Twelve Months
A year holds 13 four-week blocks, not 12. Four live billing patterns in GLP-1 care, the remainder each one creates, and how to tell which one you are on.
ReadWhat a GLP-1 Membership Fee Actually Buys
Most GLP-1 telehealth bills have two lines, and the membership is the one that moves. Four operators, four different definitions, and how to price the fee.
ReadWhy Your Second Refill Costs More Than Your First
Three mechanisms move a GLP-1 price between fill one and fill two, and they stack. What each looks like, and how to price month two before you buy month one.
Read503A or 503B: Which Kind of Pharmacy Filled Your Vial
Two legal categories hide behind one word on an invoice. What the FDA says separates them, which costs more to run, and why only one is publicly checkable.
ReadCash-Pay or Insurance: The Number That Decides It
Not price against price. Cash spending and covered spending fill different ledgers, and only one has a ceiling. Where the crossover actually sits.
ReadHow to Read a GLP-1 Provider's Pricing Page
Six questions the headline number has to answer before it means anything, run against three real pricing pages — and the two-line test that settles the rest.
ReadZepbound vs Wegovy: Which Is Cheaper Depends on Who Is Buying
Cash-pay, Zepbound costs $100 a month more than Wegovy. At what pharmacies pay to stock them, Wegovy costs $254 more. Both figures are first-party.
ReadMounjaro vs Ozempic: One Flat Price Against a Four-Step Ladder
Lilly charges $499 for every Mounjaro dose. Novo charges $149 to $499 for Ozempic depending on dose and form. Where the two lines cross, with the arithmetic.
ReadCompounded Semaglutide vs Branded Wegovy: The Gap Has Nearly Closed
A year of branded Wegovy tablets from Novo costs $3,338. A year of compounded semaglutide at two major sellers costs more. Priced from first-party pages.
ReadCompounded Tirzepatide vs Branded Zepbound: They Now Collide at $449
One compounded tirzepatide plan charges $449 a month. LillyDirect charges $449 for the FDA-approved drug. What actually sets the price is the layer in between.
ReadWhat LillyDirect Actually Costs, Product by Product
LillyDirect lists eleven medicines and publishes a self-pay price for three. Every figure, plus the two different definitions of a month on the same site.
ReadWhat NovoCare Pharmacy Actually Costs, Dose by Dose
Novo prices every Wegovy and Ozempic dose it sells. The traps are two different expiry dates, a $100 ceiling on the $25 offer, and what cash-pay does to Part D.
ReadOral Semaglutide: What the Tablet Costs Against the Pen
Novo's semaglutide tablet costs about $900 a year less than the pen. Pharmacies pay within five dollars of the same for both. The gap is a pricing decision.
ReadSwitching From Compounded to Branded: How Big the Step Really Is
Switching is not one price replacing another. Four charges change at once, and the introductory price you were counting on is usually out of reach.
ReadGLP-1 Costs by Dose: Does Titrating Up Actually Cost More?
Four different pricing philosophies are live at once. And on CMS acquisition data, a higher dose costs more in exactly one product out of every one we checked.
ReadWhat Happens to Your Price When You Reach Maintenance
Every branded GLP-1 we priced rises 50% to 151% between the first fill and the plateau — and the introductory offer expires on the fill you titrate past it.
ReadThe True Cost of Stopping and Restarting a GLP-1
Stopping is free. Restarting costs you the introductory price, the refill window, and anything you prepaid — five mechanisms, each with a number attached.
Read